Article Detail - JE Part A
MolDX: Predictive Classifiers for Early Stage Non-Small Cell Lung Cancer Final LCD - Effective August 24, 2020
This Local Coverage Determination (LCD) has completed the Open Public Meeting and Contractor Advisory Committee (CAC) comment period and is now finalized under contractor numbers: 01111 (CA), 01211 (AS, GU, HI, NMI), 01311 (NV), and 01911 (CA, HI & Territories). Responses to comments received may be found as a link at the bottom of the final LCD.
Medicare Coverage Database (MCD) Number/Contractor Determination Number: L38327
LCD Title: MolDX: Predictive Classifiers for Early Stage Non-Small Cell Lung Cancer
Effective Date: August 24, 2020
Summary of LCD: This policy concerns the use of molecular diagnostic laboratory tests (tests of DNA, RNA, and / or proteins) as a predictive classifier for non-small cell lung cancer (NSCLC) and provides criteria for coverage.
Visit the Future LCDs webpage to access this LCD.
Last Updated Mon, 13 Jul 2020 20:14:17 +0000